Patent · US Active

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

US9518096B2 · kind B2 · utility

20Cited by
18References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 25, 2014
Grant dateDec 13, 2016
Priority date
Expiry dateJul 25, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides polypeptides having a composite amino acid sequence derived from a consensus sequence representing the capsid proteins of two or more circulating strains of a non-enveloped virus. In particular, the invention provides virus-like particles comprising at least one composite polypeptide. Such virus-like particles have antigenic epitopes of two or more circulating strains of a non-enveloped virus and produce an increase in antisera cross-reactivity to one or more circulating strains of the non-enveloped virus. Methods of making composite virus-like particles and vaccine formulations comprising composite virus-like particles are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.